Chemoradiotherapy and Anti-PD-1 Antibody in Anal Squamous Cell Cancer：Chase

NCT07555678 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

241

Enrollment

OTHER

Sponsor class

Conditions

Anal Squamous Cell Cancer

Interventions

DRUG: PD-1 Inhibitor + Chemotherapy

Sponsor

Fudan University